Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Maria del Mar Puertas"'
Autor:
Sara Jiménez-Puertas, Andrea González Rodríguez, Sergio Lozares Cordero, Tomás González González, Javier Díez Chamarro, Mónica Hernández Hernández, Raquel Castro Moreno, Marta Sánchez Casi, David Carlos Villa Gazulla, Almudena Gandía Martínez, Arantxa Campos Bonel, Maria del Mar Puertas Valiño, José Antonio Font Gómez
Publikováno v:
Journal of Medical Physics, Vol 49, Iss 2, Pp 250-260 (2024)
Purpose: This study aims to minimize monitor units (MUs) of intensity-modulated treatments in the Monaco treatment planning system while preserving plan quality by optimizing the “Minimum Segment Width” (MSW) and “Fluence Smoothing” parameter
Externí odkaz:
https://doaj.org/article/3f1ca2140b9e49938bd308b6fb73fc76
Autor:
Jiménez-Puertas, Sara, González Rodríguez, Andrea, Lozares Cordero, Sergio, González González, Tomás, Díez Chamarro, Javier, Hernández Hernández, Mónica, Castro Moreno, Raquel, Sánchez Casi, Marta, Villa Gazulla, David Carlos, Gandía Martínez, Almudena, Campos Bonel, Arantxa, Valiño, Maria del Mar Puertas, Font Gómez, José Antonio
Publikováno v:
Journal of Medical Physics; Apr-Jun2024, Vol. 49 Issue 2, p250-260, 13p
Autor:
Javier Martinez-Trufero, Vicente Alonso, Antonio Antón, Miriam Zorrilla, Teresa Puertolas, Angel Artal, Maria del Mar Puertas, Ana Herrero, Joan Maurel
Publikováno v:
Anti-Cancer Drugs. 12:713-717
Gemcitabine (2',2'-difluorodeoxycytidine) is a nucleoside analog with antitumor activity against a variety of malignancies. The critical enzyme cytidine kinase is saturated at plasma concentrations achieved after a 30-min infusion at conventional dos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b337b820f56da48c9c873a68c00e6d1e
https://doi.org/10.1097/00001813-200110000-00001
https://doi.org/10.1097/00001813-200110000-00001
Publikováno v:
Health & Medicine Week; 7/26/2024, p6824-6824, 1p